NL-OMON46464Not yet recruitingNot Applicable
AFLD and NASH in HIV-patients, prevalence and risk factors. - NAFLD and NASH in HIV-patients
Erasmus MC, Universitair Medisch Centrum Rotterdam0 sites1,000 target enrollmentStarted: TBDLast updated:
Conditions
Trial Snapshot
- Phase
- Not Applicable
- Status
- Not yet recruiting
- Enrollment
- 1,000
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 18 to 99 (—)
Inclusion Criteria
- •Unselected adult HIV-infected patients visiting the outpatient clinic of a major HIV reference centers in the Netherland (Erasmus MC).
Exclusion Criteria
- •* Excessive alcohol consumption (> 5 glasses per day)
- •* (History of) hepatocellular carcinoma
- •* Liver transplant in the past
- •* Contraindications fibroscan (pregnancy, pacemaker)
- •* Other liver diseases (autoimmune hepatitis, hemochromatosis, Wilson's disease).
- •Note: Chronic hepatitis B and C are not exclusionary criteria.
Investigators
Similar Trials
Unknown
Not Applicable
NAFLD in HIV-infected PatientsHIV-infection/AidsNAFLDNCT04215926Shanghai Public Health Clinical Center400
Unknown
Not Applicable
NASH and Coronary DiseaseNon-Alcoholic Fatty Liver DiseaseNCT03819283Assistance Publique - Hôpitaux de Paris260
Completed
Phase 2
Aramchol for HIV-associated Nonalcoholic Fatty Liver Disease and LipodystrophyHIVNonalcoholic Fatty Liver DiseaseNCT02684591University of California, San Diego50
Completed
Not Applicable
PREVAIL VIII: A CoHOrt Clinical, Viral, and ImmuNOlogic Monitoring Study of People Living With Retroviral Infection in Liberia (HONOR)HIVNCT03733093National Institute of Allergy and Infectious Diseases (NIAID)1,377
Completed
Not Applicable
Prevalence and Determinants of Chronic Obstructive Pulmonary Disease (COPD) in HIV+ PatientsCOPDHIV InfectionsNCT00904384Cimera350